Difficulties in correcting hyperphosphatemia in patients with chronic renal failure. A place of noncalcium-containing phosphate-binding drugs

Abstract

The review considers the current views of the mechanisms of hyperphosphatemia in patients with chronic renal failure. It shows indications for the use of different classes of phosphate-binding drugs to correct hyperphosphatemia.

Keywords

• chronic renal failure
• hyperphosphatemia
• fibroblast growth factor 23
• klotho
• phosphate-bindings drugs